IFM Investors Pty Ltd Increases Stock Holdings in Celsius Holdings, Inc. (NASDAQ:CELH)

IFM Investors Pty Ltd increased its stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH) by 2.2% during the 1st quarter, HoldingsChannel.com reports. The fund owned 33,969 shares of the company’s stock after purchasing an additional 725 shares during the period. IFM Investors Pty Ltd’s holdings in Celsius were worth $2,817,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of CELH. National Bank of Canada FI increased its position in shares of Celsius by 52.3% during the third quarter. National Bank of Canada FI now owns 489 shares of the company’s stock worth $85,000 after acquiring an additional 168 shares during the last quarter. CWM LLC increased its holdings in Celsius by 100.6% during the 3rd quarter. CWM LLC now owns 1,015 shares of the company’s stock worth $174,000 after purchasing an additional 509 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Celsius by 191.3% in the 3rd quarter. SG Americas Securities LLC now owns 16,167 shares of the company’s stock valued at $2,774,000 after purchasing an additional 10,618 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in shares of Celsius by 16.0% during the 3rd quarter. State of Alaska Department of Revenue now owns 5,848 shares of the company’s stock valued at $1,003,000 after buying an additional 805 shares during the last quarter. Finally, Meridian Wealth Management LLC bought a new stake in shares of Celsius in the third quarter worth $357,000. Institutional investors and hedge funds own 60.95% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Maxim Group raised their price objective on shares of Celsius from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Piper Sandler lifted their price target on Celsius from $76.00 to $90.00 and gave the stock an “overweight” rating in a research note on Friday, March 1st. Morgan Stanley reissued an “equal weight” rating and set a $75.00 price target on shares of Celsius in a research report on Wednesday, March 27th. Stifel Europe lifted their price objective on shares of Celsius from $90.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, March 18th. Finally, Roth Mkm boosted their target price on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $85.10.

Insider Transactions at Celsius

In other Celsius news, CFO Jarrod Langhans sold 4,079 shares of the firm’s stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $69.42, for a total transaction of $283,164.18. Following the transaction, the chief financial officer now owns 83,670 shares of the company’s stock, valued at approximately $5,808,371.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, Director Caroline S. Levy sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total transaction of $1,895,400.00. Following the completion of the transaction, the director now owns 37,891 shares in the company, valued at approximately $3,590,930.07. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Jarrod Langhans sold 4,079 shares of Celsius stock in a transaction that occurred on Friday, April 19th. The stock was sold at an average price of $69.42, for a total transaction of $283,164.18. Following the completion of the transaction, the chief financial officer now directly owns 83,670 shares in the company, valued at approximately $5,808,371.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 652,319 shares of company stock valued at $43,575,475. 2.20% of the stock is currently owned by corporate insiders.

Celsius Trading Up 2.1 %

NASDAQ:CELH traded up $1.52 during mid-day trading on Friday, hitting $73.16. The stock had a trading volume of 1,613,270 shares, compared to its average volume of 3,685,534. The company has a 50 day simple moving average of $79.78 and a 200-day simple moving average of $64.82. The stock has a market capitalization of $16.90 billion, a price-to-earnings ratio of 94.61, a P/E/G ratio of 2.09 and a beta of 1.86. Celsius Holdings, Inc. has a 52 week low of $29.92 and a 52 week high of $99.62.

Celsius (NASDAQ:CELH) last released its quarterly earnings results on Thursday, February 29th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The company had revenue of $347.44 million for the quarter, compared to analysts’ expectations of $326.77 million. During the same quarter in the previous year, the company posted $0.01 earnings per share. The business’s revenue for the quarter was up 95.2% compared to the same quarter last year. As a group, equities research analysts anticipate that Celsius Holdings, Inc. will post 1.09 earnings per share for the current year.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.